Curie Therapeutics

Boston, United States

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Dec 2021

Series A

Health Care Medical Pharmaceutical

Top Investors

RA Capital ManagementAtlas VentureAccess Biotechnology

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Curie Therapeutics

Who are Curie Therapeutics's investors?

Curie Therapeutics's investors include RA Capital Management, Atlas Venture, Access Biotechnology.

Where is Curie Therapeutics headquartered?

Curie Therapeutics is headquartered in Boston, United States.

What does Curie Therapeutics do?

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

What stage is Curie Therapeutics at?

Curie Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2021.

MLA

"Curie Therapeutics — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/curie-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Curie Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/curie-therapeutics

Wikipedia (cite web)

{{cite web |title=Curie Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/curie-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2021.

Similar Companies in Health Care

Circl Brain Health Metrics